SCHEMBL29978640

SCHEMBL29978640

Nc1cc(Cl)c(Cl)cc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.67
GAA P10253 2/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 1/20 0.56
HPGD P15428 1/20 0.56
ERBB2 P04626 1/20 0.53
HSP90AA1 P07900 1/20 0.53
HSP90AB1 P08238 1/20 0.53
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
APP P05067 1/20 0.50
PIK3CD O00329 2/20 0.49
PIK3CG P48736 2/20 0.49
PTGES2 Q9H7Z7 2/20 0.49
PIK3CA P42336 1/20 0.49
PIK3CB P42338 1/20 0.49
FFAR4 Q5NUL3 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259968 0.83 HSD17B2 (0.67) HSD17B2GAAALDH1A1APPPTGES2
SCHEMBL1138730 0.82 ERBB2 (0.68) HSD17B2ALDH1A1ERBB2HSP90AA1HSP90AB1
SCHEMBL1913762 0.81 ERBB2 (0.62) HSD17B2GAAALOX15HSD17B10MEN1
SCHEMBL29979845 0.80 HSD17B2 (0.67) HSD17B2APPFFAR4KEAP1
SCHEMBL17340514 0.80 HSD17B2 (0.75) HSD17B2MEN1KMT2AAPPPTGES2
SCHEMBL29978689 0.80 HSD17B2 (1.00) HSD17B2MEN1KMT2AALDH1A1APP
SCHEMBL8307085 0.80 CRHBP (0.62) GAAALOX15HSD17B10MEN1KMT2A
SCHEMBL17526169 0.79 KEAP1 (0.56) GAAALOX15HSD17B10MEN1KMT2A
SCHEMBL17340527 0.79 HSD17B2 (0.61) HSD17B2GAAALOX15HSD17B10MEN1
SCHEMBL6803322 0.77 GAA (0.60) GAAALOX15HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11459287-B1 Arene-immobilized ru(II)TsDPEN complexes: synthesis and applications to the asymetric transfer hydrogenation of ketones KING ABDULAZIZ UNIVERSITY (SA) 2022-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11459287-B1 Arene-immobilized ru(II)TsDPEN complexes: synthesis and applications to the asymetric transfer hydrogenation of ketones ADH1A, KLF10, TKT HSD17B2 315/4885GAA 3401/4885ALOX15 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.